ClinicalTrials.Veeva

Menu

Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease

R

Region Örebro County

Status

Terminated

Conditions

Aortic Valve Stenosis

Study type

Observational

Funder types

Other

Identifiers

NCT01939678
2012-12

Details and patient eligibility

About

The purpose of this study is to investigate whether mutations in genes coding for Na/Pi-cotransporters are associated with aortic valve calcification. A patient population with premature aortic valve calcification treated with aortic valve replacement will be screened for mutations in these specific genes. Furthermore, aortic valve tissue received from the operations, will be examined for the presence of Na/Pi-cotransporters, and for molecular characterization of the transporters.

Enrollment

3 patients

Sex

All

Ages

Under 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with aortic valve calcification that will be treated with an aortic valve replacement.
  • Age ≤ 65 years.
  • Signed and dated informed consent.

Exclusion criteria

  • Inability to provide informed consent
  • Earlier radiation therapy of the thorax
  • Severe renal disease (patients in treatment with dialysis)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems